Besides being just crummy all around, 2020 wasn’t a particularly eventful year for intellectual property.

The Supreme Court decided six cases of relatively minor consequence. The U.S. Court of Appeals for the Federal Circuit didn’t rock the patent bar the way it did with 2019′s Arthrex decision. Jury trials were few and far between after February. The Eastern District of Texas reopened in the summer for a handful of trials, including two $500 million patent verdicts against Apple Inc., then closed again following a courtroom COVID-19 outbreak in November. We had a smattering of fully virtual bench trials in patent cases, including one that ended in a $1.9 billion award.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]